Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-25-153739
Filing Date
2025-07-01
Accepted
2025-07-01 11:01:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC14D9C d84611dsc14d9c.htm SC14D9C 19170
2 EX-99.1 d84611dex991.htm EX-99.1 11789
3 EX-99.2 d84611dex992.htm EX-99.2 9397
  Complete submission text file 0001193125-25-153739.txt   42147
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filed by) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Subject) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-91132 | Film No.: 251094750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)